Published in Cancer Res on May 01, 1976
Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70
Micromethod for the determination of free and total prolactin receptors: measurement of receptor levels in normal and malignant mammary and prostate tissues. Proc Natl Acad Sci U S A (1986) 0.79
Determination and properties of proteohormone receptors in malignant gynecological tumors with special reference to lactogen receptors in human breast cancer. Arch Gynecol (1980) 0.75
Season of initial discovery of tumour as an independent variable predicting survival in breast cancer. Br J Cancer (1990) 2.55
Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol (1990) 2.46
Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem Biophys Res Commun (1971) 2.07
Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Endocrinology (1974) 1.81
Prolactin, phenothiazines, admission to mental hospital, and carcinoma of the breast. Lancet (1973) 1.80
Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med (1978) 1.76
Radioreceptor assay for growth hormone. J Clin Endocrinol Metab (1973) 1.66
Solubilization and purification of a prolactin receptor from the rabbit mammary gland. J Biol Chem (1974) 1.65
Molecular cloning and expression of peptide 23, a growth hormone-releasing hormone-inducible pituitary protein. Endocrinology (1995) 1.63
Radioreceptor assay for prolactin and other lactogenic hormones. Science (1973) 1.56
Lung tumours and ACTH production. Clin Endocrinol (Oxf) (1977) 1.54
Equal opportunities in Canada. Nature (1998) 1.50
The separation of monkey prolactin from monkey growth hormone by affinity chromatography. Biochem Biophys Res Commun (1971) 1.48
The acromegalic rosary. Lancet (1991) 1.43
Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) (1994) 1.40
A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. J Clin Endocrinol Metab (1980) 1.39
Variation in receptor status between primary and metastatic breast cancer. Cancer (1983) 1.36
Estrogen induces insulin-like growth factor-I expression in the rat uterus. Mol Endocrinol (1987) 1.36
Properties of a prolactin receptor from the rabbit mammary gland. Biochem J (1974) 1.35
Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy. Endocrinology (1974) 1.35
Purification and partial characterization of a nonprimate growth hormone receptor. J Biol Chem (1979) 1.34
Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res (1983) 1.31
The educational, vocational, and marital status of growth hormone-deficient adults treated with growth hormone during childhood. Am J Dis Child (1985) 1.30
Human placental lactogen. An index of placental function. Obstet Gynecol (1970) 1.28
Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem (1990) 1.28
Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol (Copenh) (1983) 1.28
Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. Cancer Res (1982) 1.21
Induction of a lactogenic receptor in rat liver: influence of estrogen and the pituitary. Proc Natl Acad Sci U S A (1974) 1.18
Studies of prolactin secretion in human pregnancy. Am J Obstet Gynecol (1972) 1.15
Prolactin receptors in rat liver: possible induction by prolactin. Science (1975) 1.15
The nature and regulation of the receptors for pituitary growth hormone. Annu Rev Physiol (1985) 1.13
A human B-lymphoblastoid cell line produces prolactin. Endocrinology (1988) 1.13
An unusual cause of hyperinsulinaemic hypoglycaemia syndrome. Diabet Med (2003) 1.12
Serum prolactin levels in humans from birth to adult life. Pediatr Res (1973) 1.11
Human lactational and ovarian response to endogenous prolactin release. Science (1972) 1.11
Blockade of prolactin action by an antiserum to its receptors. Science (1976) 1.11
Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol (Oxf) (1992) 1.11
Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J Biol Chem (1987) 1.11
Serum fructosamine concentration as measure of blood glucose control in type I (insulin dependent) diabetes mellitus. Br Med J (Clin Res Ed) (1985) 1.10
Biosynthesis of monkey growth hormone and prolactin in vitro. Endocrinology (1971) 1.10
Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology (1987) 1.10
Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group. Int J Cancer (1996) 1.09
The characterization of growth factor activity in human brain. J Biol Chem (1981) 1.08
Survival of women with node negative breast cancer in the Auckland region. N Z Med J (1996) 1.08
Analysis of growth hormone and lactogenic binding sites cross-linked to iodinated human growth hormone. Endocrinology (1983) 1.07
Reliability of steroid hormone receptor assays: an international study. Eur J Cancer Clin Oncol (1983) 1.06
Circulating corticotrophin levels in severe hypopituitarism and in the neonate. Lancet (1973) 1.05
Changes in neurohypophysial proteins induced by dehydration and ingestion of saline. Endocrinology (1967) 1.04
Interrelationships in the regulation of TSH and prolactin secretion in man: effects of L-dopa, TRH and thyroid hormone in various combinations. J Clin Endocrinol Metab (1974) 1.04
Characteristics of solubilized human-somatotropin-binding protein from the liver of pregnant rabbits. Biochem J (1980) 1.03
Characterization of the two forms of rat placental lactogen (rPL): rPL-I and rPL-II. Endocrinology (1982) 1.03
Functional evaluation of prolactin secretion in patients with hypothalamic-pituitary disorders. J Clin Invest (1973) 1.02
Seasonal variation in breast cancer detection: correlation with tumour progesterone receptor status. Breast Cancer Res Treat (1985) 1.02
Association between season of first detection of breast cancer and disease progression. Breast Cancer Res Treat (1987) 1.01
Growth hormone therapy in Canada: end of one era and beginning of another. CMAJ (1986) 1.01
Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. J Biol Chem (1987) 1.01
Studies on the irreversible nature of prolactin binding to receptors. Endocrinology (1980) 1.00
Synthesis and secretion of placental lactogen and other proteins by the placenta. Recent Prog Horm Res (1969) 1.00
Detection of familial dysalbuminaemic hyperthyroxinaemia. Br Med J (Clin Res Ed) (1985) 1.00
Receptor-mediated mitogenic action of prolactin in a rat lymphoma cell line. Endocrinology (1983) 1.00
Two forms of rat placental lactogen revealed by radioimmunoassay. Endocrinology (1981) 1.00
Studies on the regulation and characterization of plasma stanniocalcin in rainbow trout. Mol Cell Endocrinol (1991) 1.00
Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. Am J Obstet Gynecol (1973) 0.99
New bioassay for luteinizing hormone. Nature (1973) 0.99
The MRC: meeting the challenges of tomorrow. CMAJ (1993) 0.99
Changes of immunoreactive somatostatin and beta-endorphin content in rat brain after amygdaloid kindling. Life Sci (1983) 0.97
Abnormal insulin-receptor down regulation and dissociation of down regulation from insulin biological action in cultured human tumor cells. Cancer Res (1987) 0.97
Interaction of cell-membrane prolactin receptor with its antibody. Biochem J (1976) 0.95
Hormone binding by human mammary carcinoma. Cancer Res (1977) 0.94
Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum. J Clin Endocrinol Metab (1973) 0.94
Growth hormone and insulin binding to human liver. J Clin Endocrinol Metab (1976) 0.93
Validation of the redox cytochemical assay for corticotrophin. Clin Endocrinol (Oxf) (1974) 0.93
A monoclonal antibody to the growth hormone receptor of rabbit liver membranes. Endocrinology (1983) 0.92
Progesterone and oestrogen receptors in human breast cancer. Aust N Z J Med (1978) 0.92
Identification, characterization, and regulation of a rat complementary deoxyribonucleic acid which encodes insulin-like growth factor-I. Endocrinology (1987) 0.92
20K is bound with high affinity by one rat and one of two rabbit growth hormone receptors. Endocrinology (1983) 0.92
Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas. Mol Endocrinol (1989) 0.91
12-O-tetradecanoyl phorbol-13-acetate stimulates rat growth hormone (GH) release through different pathways from that of human pancreatic GH-releasing factor. Endocrinology (1985) 0.91
The purification and characterization of ovine placental lactogen. Endocrinology (1976) 0.91
Fibroblast growth factor release by bovine endothelial cells and human astrocytoma cells in culture is density dependent. Mol Endocrinol (1989) 0.91
Physiological factors regulating secretion of neurophysin. Metabolism (1970) 0.90
Effectof sex, oral contraceptives, and glucose loading on apomorphine-induced growth hormone secretion. J Clin Endocrinol Metab (1975) 0.90
A growth hormone binding factor in the serum of pregnant mice. Endocrinology (1977) 0.90
Insulin receptor regulation in cultured human tumor cells. Cancer Res (1983) 0.90
Thyrotropin releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitary dwarfism: further evidence for hypophysiotropic hormone deficiencies. J Clin Endocrinol Metab (1972) 0.90
The hormone-synthesizing trophoblastic cell in vitro: a model for cancer research and placental hormone synthesis. Ann N Y Acad Sci (1971) 0.89
Fibroblast growth factor messenger ribonucleic acid expression in a human astrocytoma cell line: regulation by serum and cell density. Mol Endocrinol (1988) 0.89
Growth hormone stimulates sequential induction of c-myc and insulin-like growth factor I expression in vivo. Endocrinology (1987) 0.89
Mechanism of action of prolactin in the control of mammary gland function. Annu Rev Physiol (1980) 0.89
Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: relation to pituitary tumor. J Clin Endocrinol Metab (1993) 0.89
The isolation and characterization of human neurophysin. J Clin Endocrinol Metab (1972) 0.89
Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging. Intern Med J (2003) 0.89
Expression of pituitary peptide 23 in the rat uterus: regulation by estradiol. Mol Cell Endocrinol (1995) 0.89
Modification of superoxide dismutase in rat mammary carcinoma. Res Commun Chem Pathol Pharmacol (1977) 0.88
Localization of prolactin binding in prostate and testis: The role of serum prolactin concentration on the testicular LH receptor. Acta Endocrinol (Copenh) (1977) 0.88
Effect of prolactin and growth hormone on prolactin and LH receptors in the dwarf mouse. J Reprod Fertil (1976) 0.88
Milk alkali syndrome following over-the-counter antacid self-medication. N Z Med J (1986) 0.88
Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript. Mol Cell Endocrinol (1989) 0.88